Delivery Order SPE2DB20D2104-SPE2DB20FR20L
- Not listed
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to the U.S. government. The award, with a ceiling value of $1,286.44, was issued by the Defense Logistics Agency (DLA) and is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to deliver...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $7,556.17, was awarded by the Defense Logistics Agency (DLA) and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide essential medical commodities,...
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $2,630.74, is a delivery order awarded by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of a wide range of pharmaceutical products and medical supplies to the U.S. government. The award was made by the Defense Logistics Agency (DLA) through a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide essential medications,...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,490.40, was awarded by the Defense Logistics Agency (DLA) and is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the company's parent, Cencora, Inc., valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a wide range of pharmaceutical products and medical supplies to support various government healthcare programs, particularly within the military and veterans' healthcare systems. The contract, valued at $1,834.44, was awarded by the Defense Logistics Agency (DLA) and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $45,183.00, was awarded by the Defense Logistics Agency (DLA) and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This single-award IDC serves as the primary vehicle for Amerisourcebergen Drug Corp to deliver a comprehensive...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for providing a wide range of pharmaceutical products and medical supplies to support various U.S. government healthcare programs. The contract has a ceiling value of $7,511.82 and is a delivery order issued under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00. This IDC serves as the primary vehicle for...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver a wide range of pharmaceutical products and medical supplies to the U.S. government. The $13,003.97 delivery order was issued by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of a wide range of pharmaceutical products and medical supplies to support federal government healthcare programs. The contract, awarded by the Defense Logistics Agency (DLA), is a $3,059.96 delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC serves as the primary vehicle for...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB20FR20LDelivery Order
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, with a ceiling value of $13,950.57, was awarded by the Defense Logistics Agency (DLA) as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to deliver essential medications, medical devices, and other healthcare commodities to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen's parent company, Cencora, Inc., also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 8/20/20 |